Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Van Cott

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Archives of Pathology & Laboratory Medicine|September 19, 2017
Rivaroxaban Causes Missed Diagnosis of Protein S Deficiency but Not of Activated Protein C Resistance (Factor V Leiden)Elena Maryamchik, Matthew W Rosenbaum, Elizabeth M Van Cott
American Journal of Clinical Pathology|January 31, 2004
Biphasic activated partial thromboplastin time waveform and adverse events in non-intensive care unit patientsEve Y Smith, Linda A Charles, Elizabeth M Van Cott
Seminars in Thrombosis and Hemostasis|June 14, 2017
Response to: "More on the Limitations of the aPTT for Monitoring Argatroban Therapy"Elizabeth M Van Cott, A Joshua Roberts, William E Dager
American Journal of Clinical Pathology|August 7, 2002
Elevated fibrinogen in an acute phase reaction prolongs the reptilase time but typically not the thrombin timeElizabeth M Van Cott, Eve Y Smith, Dennis K Galanakis
Thrombosis Research|January 24, 2012
Assessment of a cohort of primarily pediatric patients with a presumptive diagnosis of type 1 von Willebrand disease with a novel high shear rate, non-citrated blood flow deviceEric F Grabowski, Marjorie A Curran, Elizabeth M Van Cott
American Journal of Clinical Pathology|August 18, 2011
Acquired activated protein C resistance caused by lupus anticoagulantsAdam J Saenz, Nicholas V Johnson, Elizabeth M Van Cott
Seminars in Thrombosis and Hemostasis|January 5, 2017
Laboratory Monitoring of Parenteral Direct Thrombin InhibitorsElizabeth M Van Cott, A Joshua Roberts, William E Dager
American Journal of Hematology|January 23, 2010
von Willebrand disease type 2N: uncovering a congenital bleeding disorder in a patient with hepatitis C, cirrhosis, and coagulopathyAndrew A Lane, Elizabeth M Van Cott, Bimalangshu R Dey
Annals of Hematology|November 18, 2018
Platelet aggregation response in immune thrombocytopenia patients treated with romiplostimHanny Al-Samkari, Elizabeth M Van Cott, David J Kuter
Transfusion|August 5, 2008
Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistanceJohn F Staropoli, Elizabeth M Van Cott, Robert S Makar
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Archives of Pathology & Laboratory Medicine|September 19, 2017
Rivaroxaban Causes Missed Diagnosis of Protein S Deficiency but Not of Activated Protein C Resistance (Factor V Leiden)Elena Maryamchik, Matthew W Rosenbaum, Elizabeth M Van Cott
American Journal of Clinical Pathology|January 31, 2004
Biphasic activated partial thromboplastin time waveform and adverse events in non-intensive care unit patientsEve Y Smith, Linda A Charles, Elizabeth M Van Cott
Seminars in Thrombosis and Hemostasis|June 14, 2017
Response to: "More on the Limitations of the aPTT for Monitoring Argatroban Therapy"Elizabeth M Van Cott, A Joshua Roberts, William E Dager
American Journal of Clinical Pathology|August 7, 2002
Elevated fibrinogen in an acute phase reaction prolongs the reptilase time but typically not the thrombin timeElizabeth M Van Cott, Eve Y Smith, Dennis K Galanakis
Thrombosis Research|January 24, 2012
Assessment of a cohort of primarily pediatric patients with a presumptive diagnosis of type 1 von Willebrand disease with a novel high shear rate, non-citrated blood flow deviceEric F Grabowski, Marjorie A Curran, Elizabeth M Van Cott
American Journal of Clinical Pathology|August 18, 2011
Acquired activated protein C resistance caused by lupus anticoagulantsAdam J Saenz, Nicholas V Johnson, Elizabeth M Van Cott
Seminars in Thrombosis and Hemostasis|January 5, 2017
Laboratory Monitoring of Parenteral Direct Thrombin InhibitorsElizabeth M Van Cott, A Joshua Roberts, William E Dager
American Journal of Hematology|January 23, 2010
von Willebrand disease type 2N: uncovering a congenital bleeding disorder in a patient with hepatitis C, cirrhosis, and coagulopathyAndrew A Lane, Elizabeth M Van Cott, Bimalangshu R Dey
Annals of Hematology|November 18, 2018
Platelet aggregation response in immune thrombocytopenia patients treated with romiplostimHanny Al-Samkari, Elizabeth M Van Cott, David J Kuter
Transfusion|August 5, 2008
Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistanceJohn F Staropoli, Elizabeth M Van Cott, Robert S Makar
Pageof 11